Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Life Sciences

formerly Central European Journal of Biology

Editor-in-Chief: Ratajczak, Mariusz

1 Issue per year


IMPACT FACTOR 2016 (Open Life Sciences): 0.448

CiteScore 2016: 1.02

SCImago Journal Rank (SJR) 2016: 0.329
Source Normalized Impact per Paper (SNIP) 2016: 0.621

Open Access
Online
ISSN
2391-5412
See all formats and pricing
More options …
Volume 9, Issue 10 (Oct 2014)

Issues

The study of hyaluronic acid compounds for neutron capture and photon activation therapies

Sergey Koryakin / Vera Yadrovskaya / Evgeny Beketov / Elena Isaeva / Stepan Ulyanenko / Sergey Uspenskiy / Vladimir Khabarov / Mikhail Selyanin
Published Online: 2014-08-15 | DOI: https://doi.org/10.2478/s11535-014-0329-7

Abstract

The therapy of radioresistant tumors remains an urgent problem in medicine. To solve this problem neutron capture therapy (NCT) and photon activation therapy (PAT) are used. The essential feature of this such technique is the uptake of tumor chemical elements, which interact with thermal neutrons (NCT) and X-rays (PAT). The aims of the investigation were to study a biodistribution of the complexes of hyaluronic acid with boron (3 mg B mL−1) and gold (20 mg Au mL−1) in mice with melanoma B-16 after intratumoral administration. An optimal time for NCT was 30 minutes after administration when boron concentration in the tumor was more than 30 μg g−1 and exceeded boron content in surrounding tissues. The maximal gold content in tumor (180–260 mg g−1) was obtained in 30 minutes after the preparation introduction. The highest ratios of gold in tumor and surrounding tissues (a necessary condition for forming of the local absorbed dose in tumor) was obtained in 0.5 and 1 h. On the basis of the data obtained, it is possible to assume the perspectives of the non-toxic boron compounds for use in NCT and the gold compounds for use primarily as contrast agents for diagnostic purposes.

Keywords: Boron; Gold; Melanoma B-16; Intratumoral Administration; Biodistribution; NCT; PAT

  • [1] Sweet W.H., Early history of development of boron neutron capture therapy of tumors, J. Neuro- Oncology., 1997, 1-2, 19–26 http://dx.doi.org/10.1023/A:1005752827194CrossrefGoogle Scholar

  • [2] Barth R.F., Soloway A.H., Brugger R.M., Boron neutron capture therapy of brain tumors: past history, current status, and future potential, Cancer Invest., 1996, 6, 534–550 http://dx.doi.org/10.3109/07357909609076899CrossrefGoogle Scholar

  • [3] Soloway A.H., Tjarks W., Barnum B.A., Rong F.G., Barth R.F., Codogni I.M. et al, The chemistry of neutron capture therapy, Chem. Rev., 1998, 4, 1515–1562 http://dx.doi.org/10.1021/cr941195uCrossrefGoogle Scholar

  • [4] Koryakin S. N., Compounds for neutron capture therapy and their distribution in tumors and surrounding tissues of animals (a review), Pharmaceutical Chemistry Journal, 2006, 11, 583–587 http://dx.doi.org/10.1007/s11094-006-0198-0CrossrefGoogle Scholar

  • [5] Matsudaira H., Ueno A.M., Furuno I., Iodine contrast medium sensitizes cultured mammalian cells to x-rays but not to γ rays, Radiat. Res., 1980, 84, 144–148 http://dx.doi.org/10.2307/3575225CrossrefGoogle Scholar

  • [6] Kobayashi K., Usami N., Porcel E., Lacombe S., Le Sech C., Enhancement of radiation effect by heavy elements, Mutation. Res., 2010, 704, 123–131 http://dx.doi.org/10.1016/j.mrrev.2010.01.002CrossrefGoogle Scholar

  • [7] Choi G.H., Seo S.J., Kim K.H., Kim H.T., Park S.H., Lim J.H., Kim J.K., Photon activated therapy (PAT) using monochromatic synchrotron X-rays and iron oxide nanoparticles in a mouse tumor model: feasibility study of PAT for the treatment of superficial malignancy, Radiation Oncology, 2012, 184, 1–10 http://dx.doi.org/10.3857/roj.2012.30.1.1CrossrefGoogle Scholar

  • [8] Hainfeld J.J., Slatkin D.N., Smilowitz H.M., The use of gold nanoparticles to enhance radiotherapy in mice, Phys. Med. Biol., 2004, 18, 309–315 http://dx.doi.org/10.1088/0031-9155/49/18/N03CrossrefGoogle Scholar

  • [9] Rahman W.N., Ackerly T., He C.F., Jackson P., Wong C., Davidson R. et al., Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy, Nanomedicine, 2009, 5, 136–142 CrossrefGoogle Scholar

  • [10] Duncan R., The dawning era of polymer therapeutics, Nat. Rev. Drug Discov., 2003, 2, 347–360 http://dx.doi.org/10.1038/nrd1088CrossrefGoogle Scholar

  • [11] Farokhzad O.C., Langer R., Nanomedicine: developing smarter therapeutic and diagnostic modalities, Adv. Drug Deliv. Rev., 2006, 58, 1456–1459 http://dx.doi.org/10.1016/j.addr.2006.09.011CrossrefGoogle Scholar

  • [12] Meo C.D., Panza L., Capitani D., Mannina L., Banzato A., Rondina M. et al., Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy, Biomacromolecules, 2007, 2, 552–559 http://dx.doi.org/10.1021/bm0607426CrossrefGoogle Scholar

  • [13] Choia K.Y., Saravanakumarc G., Park J.H., Park K., Hyaluronic acid-based nanocarriers for intracellular targeting: Interfacial interactions with proteins in cancer, Colloids Surf. B. Biointerfaces, 2012, 99, 82–94 http://dx.doi.org/10.1016/j.colsurfb.2011.10.029CrossrefGoogle Scholar

  • [14] Stamenkovic I., Aruffo A., Amiot M., Seed B., The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells, EMBO J., 1991, 10, 343–348 Google Scholar

  • [15] Hien N.Q., Van Phu D., Duy N.N., Quoc L.A., Radiation synthesis and characterization of hyaluronan capped gold nanoparticles, Carbohydrate Polymers, 2012, 89, 537–541 http://dx.doi.org/10.1016/j.carbpol.2012.03.041CrossrefGoogle Scholar

  • [16] Koryakin S. N., Ivanov P. L., Khabarov V. N., Yadrovskaya V.A., Isaeva E.V., Beketov E.E. et al. The synthesis and study of new compound hyaluronic acid-based and boron-10 for neutron capture therapy, Khimiko-Farmatsevticheskii Zhurnal, 2013, 47,6, 14–18 (in Russian) Google Scholar

About the article

Published Online: 2014-08-15

Published in Print: 2014-10-01


Citation Information: Open Life Sciences, ISSN (Online) 2391-5412, DOI: https://doi.org/10.2478/s11535-014-0329-7.

Export Citation

© 2014 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in